The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

The technology – called Antibody Transport Vehicle (ATV): Amyloid beta – can be used to help amyloid-targeting drugs cross the blood brain barrier (BBB) more effectively, say the partners.

Researchers George Glenner and Caine Wong identified the amyloid beta peptide as the main component of amyloid plaques found in Alzheimer ... Eli Lilly, for instance, recently announced a $1.8 billion ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

A cognitive illness is among the top causes of death in Washington. In fact, it ranks higher in the state compared to other ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer’s therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease. Using new, ...

A team of researchers from the Institute for Basic Science (IBS) in South Korea has made an important discovery that could ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

CD47 is found to play a pivotal role in this immunosuppression by inducing the production of amyloid-β (Aβ), which interacts with CD74 on B cells, leading to B-cell suppression and subsequent adaptive ...

Credit: Lightspring / Shutterstock. At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the ‘Abeta Targeting Therapies in AD’ symposium on 3 April, Roche ...